These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17852392)

  • 1. NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis. I. Study design and clinical outcomes.
    Afriyie-Gyawu E; Ankrah NA; Huebner HJ; Ofosuhene M; Kumi J; Johnson NM; Tang L; Xu L; Jolly PE; Ellis WO; Ofori-Adjei D; Williams JH; Wang JS; Phillips TD
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2008 Jan; 25(1):76-87. PubMed ID: 17852392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis: II. Reduction in biomarkers of aflatoxin exposure in blood and urine.
    Wang P; Afriyie-Gyawu E; Tang Y; Johnson NM; Xu L; Tang L; Huebner HJ; Ankrah NA; Ofori-Adjei D; Ellis W; Jolly PE; Williams JH; Wang JS; Phillips TD
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2008 May; 25(5):622-34. PubMed ID: 18478481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NovaSil clay does not affect the concentrations of vitamins A and E and nutrient minerals in serum samples from Ghanaians at high risk for aflatoxicosis.
    Afriyie-Gyawu E; Wang Z; Ankrah NA; Xu L; Johnson NM; Tang L; Guan H; Huebner HJ; Jolly PE; Ellis WO; Taylor R; Brattin B; Ofori-Adjei D; Williams JH; Wang JS; Phillips TD
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2008 Jul; 25(7):872-84. PubMed ID: 18569006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term safety evaluation of processed calcium montmorillonite clay (NovaSil) in humans.
    Wang JS; Luo H; Billam M; Wang Z; Guan H; Tang L; Goldston T; Afriyie-Gyawu E; Lovett C; Griswold J; Brattin B; Taylor RJ; Huebner HJ; Phillips TD
    Food Addit Contam; 2005 Mar; 22(3):270-9. PubMed ID: 16019795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing human exposure to aflatoxin through the use of clay: a review.
    Phillips TD; Afriyie-Gyawu E; Williams J; Huebner H; Ankrah NA; Ofori-Adjei D; Jolly P; Johnson N; Taylor J; Marroquin-Cardona A; Xu L; Tang L; Wang JS
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2008 Feb; 25(2):134-45. PubMed ID: 18286403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic toxicological evaluation of dietary NovaSil clay in Sprague-Dawley rats.
    Afriyie-Gyawu E; Mackie J; Dash B; Wiles M; Taylor J; Huebner H; Tang L; Guan H; Wang JS; Phillips T
    Food Addit Contam; 2005 Mar; 22(3):259-69. PubMed ID: 16019794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAH exposure in a Ghanaian population at high risk for aflatoxicosis.
    Johnson NM; Afriyie-Gyawu E; Huebner H; Marroquin-Cardona A; Robinson A; Tang L; Xu L; Ankrah NA; Ofori-Adjei D; Jolly PE; Williams JH; Wang JS; Phillips TD
    Sci Total Environ; 2009 Mar; 407(6):1886-91. PubMed ID: 19144392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of aflatoxin levels in Ghanaians: sociodemographic factors, knowledge of aflatoxin and food handling and consumption practices.
    Jolly P; Jiang Y; Ellis W; Awuah R; Nnedu O; Phillips T; Wang JS; Afriyie-Gyawu E; Tang L; Person S; Williams J; Jolly C
    Int J Hyg Environ Health; 2006 Jul; 209(4):345-58. PubMed ID: 16644281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
    Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.
    Lim KS; Kim JR; Choi YJ; Shin KH; Kim KP; Hong JH; Cho JY; Shin HS; Yu KS; Shin SG; Kwon OH; Hwang DM; Kim JA; Jang IJ
    Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium montmorillonite clay reduces urinary biomarkers of fumonisin B₁ exposure in rats and humans.
    Robinson A; Johnson NM; Strey A; Taylor JF; Marroquin-Cardona A; Mitchell NJ; Afriyie-Gyawu E; Ankrah NA; Williams JH; Wang JS; Jolly PE; Nachman RJ; Phillips TD
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2012; 29(5):809-18. PubMed ID: 22324939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NovaSil clay for the protection of humans and animals from aflatoxins and other contaminants.
    Phillips TD; Wang M; Elmore SE; Hearon S; Wang JS
    Clays Clay Miner; 2019 Feb; 67(1):99-110. PubMed ID: 32943795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of aflatoxin biomarkers in human blood and urine by green tea polyphenols intervention.
    Tang L; Tang M; Xu L; Luo H; Huang T; Yu J; Zhang L; Gao W; Cox SB; Wang JS
    Carcinogenesis; 2008 Feb; 29(2):411-7. PubMed ID: 18192689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lansoprazole 15 mg once daily for 14 days is effective for treatment of frequent heartburn: results of 2 randomized, placebo-controlled, double-blind studies.
    Kushner PR; Snoddy AM; Gilderman L; Peura DA
    Postgrad Med; 2009 Jul; 121(4):67-75. PubMed ID: 19641272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
    Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.
    Lal R; Sukbuntherng J; Luo W; Chen D; Vu A; Tovera J; Cundy KC
    Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
    Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
    Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.